RIXUBIS

Product Overview

About RIXUBIS

Rixubis is a medication containing the active ingredient nonacog gamma, a recombinant human coagulation factor VIII. It is used to treat and prevent bleeding episodes in patients with hemophilia A.

Key Benefits & Uses

• Treatment and prevention of bleeding episodes in patients with hemophilia A
• On-demand treatment of bleeding episodes in patients with hemophilia A
• Prophylactic treatment to prevent bleeding episodes in patients with hemophilia A

Active Ingredient & Action

Nonacog gamma, the active ingredient in Rixubis, is a recombinant human coagulation factor VIII that helps to restore the body's ability to form blood clots. It works by replacing the deficient clotting factor VIII in patients with hemophilia A, thereby preventing excessive bleeding.

Important Notes

Rixubis should only be used under the guidance of a healthcare professional. Patients should be monitored for signs of hypersensitivity reactions, such as anaphylaxis, and should be instructed on proper injection techniques. Rixubis is available in single-dose vials and should be stored in the refrigerator at a temperature between 2°C and 8°C (36°F and 46°F).